Pulse Biosciences Files 8-K Report
Ticker: PLSE · Form: 8-K · Filed: May 20, 2024 · CIK: 1625101
| Field | Detail |
|---|---|
| Company | Pulse Biosciences, Inc. (PLSE) |
| Form Type | 8-K |
| Filed Date | May 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $60,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Pulse Biosciences filed a routine 8-K with the SEC on May 20, 2024.
AI Summary
On May 20, 2024, Pulse Biosciences, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or new material events were detailed in the provided text, but it indicates a routine filing with the SEC.
Why It Matters
This filing serves as a public record of Pulse Biosciences, Inc.'s corporate activities and financial reporting to the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report, indicating routine corporate disclosures rather than a specific event with immediate high risk.
Key Players & Entities
- Pulse Biosciences, Inc. (company) — Registrant
- May 20, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-37744 (commission_file_number) — SEC File Number
- 46-5696597 (irs_number) — IRS Employer Identification No.
- 3957 Point Eden Way, Hayward, California 94545 (address) — Principal Executive Offices
- 510-906-4600 (phone_number) — Registrant's Telephone Number
- Electroblate, Inc. (company) — Former Company Name
- 20141113 (date) — Date of Former Company Name Change
FAQ
What is the primary purpose of this 8-K filing by Pulse Biosciences, Inc.?
The primary purpose of this 8-K filing is to report "Other Events" and "Financial Statements and Exhibits" as of May 20, 2024.
When was this 8-K report filed by Pulse Biosciences, Inc.?
This 8-K report was filed on May 20, 2024.
What is the principal executive office address for Pulse Biosciences, Inc.?
The principal executive office address for Pulse Biosciences, Inc. is 3957 Point Eden Way, Hayward, California 94545.
What was the former name of Pulse Biosciences, Inc.?
The former name of Pulse Biosciences, Inc. was Electroblate, Inc., with a name change date of November 13, 2014.
What is the SEC file number for Pulse Biosciences, Inc.?
The SEC file number for Pulse Biosciences, Inc. is 001-37744.
Filing Stats: 437 words · 2 min read · ~1 pages · Grade level 10 · Accepted 2024-05-20 16:10:06
Key Financial Figures
- $0.001 — nge on Which Registered Common stock , $0.001 par value per share PLSE The Nasdaq
- $60,000,000 — ted timing of Rights Offering for up to $60,000,000. A copy of the Company's press release
Filing Documents
- plse20240520_8k.htm (8-K) — 24KB
- ex_676952.htm (EX-99.1) — 14KB
- 0001437749-24-017654.txt ( ) — 172KB
- plse-20240520.xsd (EX-101.SCH) — 3KB
- plse-20240520_def.xml (EX-101.DEF) — 11KB
- plse-20240520_lab.xml (EX-101.LAB) — 15KB
- plse-20240520_pre.xml (EX-101.PRE) — 11KB
- plse20240520_8k_htm.xml (XML) — 3KB
01
Item 8.01 Other Events. On May 20, 2024, Pulse Biosciences, Inc. (the "Company") issued a press release announcing updated timing of Rights Offering for up to $60,000,000. A copy of the Company's press release is attached as Exhibit 99.1.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release issued by Pulse Biosciences, Inc. dated May 20, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PULSE BIOSCIENCES, INC. Date: May 20, 2024 By: /s/ Burke T. Barrett Burke T. Barrett President and Chief Executive Officer (Principal Executive and Principal Financial Officer)